Measurement variation influences gene expression profiles of breast cancer

The future of PI3K/AKT/mTOR inhibitors in breast cancer

Treatment of non-small cell lung cancer and adenocarcinoma

Treating adenocarcinoma with bevacizumab

Update on the METABRIC consortium 2000 Breast Cancer Study

The Cancer Genome Atlas (TCGA): comprehensive molecular portraits of breast cancer

Genetic alterations in postmenopausal women with hormone receptor-positive, HER2-negative advanced breast cancer

Implementation of individualised treatment and the WINTHER trial

Importance of personalised medicine and the WIN Consortium

Goal of the 2013 WIN Symposium

Myc inhibition in pre-clinical mouse models

Next generation gene sequencing